Company profile
Trulieve Cannabis Corp.
NYSE: TRLV · Healthcare · Medical - Pharmaceuticals
#143 of 1,418 Healthcare companies by revenue
EA Score
——FH 72DQ —GM —SS 71
v0.1 · 35/100 weight · pillars only
↑ workforce scale, operating margin · ↓ disclosure history, listing tenure
Methodology →Revenue TTM
$1.1B
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$116.4M
Employees
5,000
as of 2026-08-09
Market cap
$1.5B
as of 2026-08-09
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.2B$1.2B2025
Net income-$116.4M-$116.4M2025
Operating income$148.3M$148.3M2025
Total assets$2.7B$2.7B2025
Liabilities$1.6B$1.6B2025
Equity$1.2B$1.2B2025
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Trulieve Cannabis Corp.’s revenue?
Trulieve Cannabis Corp. booked $1.2B in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -9.9% net margin.
Peers · Healthcare
Extendicare Inc.79B+Omnicell, Inc.78B+Trulieve Cannabis Corp.63CGreen Thumb Industries Inc.72BSotera Health Company70BNovavax, Inc.69BKey facts
CEOKimberly A. Rivers
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersTallahassee, FL
ExchangeNYSE: TRLV
Employees5,000
IPO date2018-09-25
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.